EUVIMEDEUVIMED entdecken
Crossref

(1E,4E)-1,5-bis(2-bromo-4,5-dihydroxyphenyl)penta-1,4-dien-3-one alleviates hyperuricemia by inhibiting xanthine oxidase

Qian Wang, Li Wang, Yaxin Guo, Dimitrios Stagos, Yankai Liu, Ming Liu

Bioorganic Chemistry · 2026-06 · 174 · 109745

DOI: 10.1016/j.bioorg.2026.109745 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioorganic Chemistry, 2026-06. Verfasst von Qian Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Marine Drugs, Ministry of Education, School of Medicine and Pharmacy, Ocean University of China, Qingdao 266003, China; Laboratory …. Hauptthemen laut MEDLINE: Xanthine Oxidase, Hyperuricemia, Enzyme Inhibitors. Die Arbeit nennt 55 Literaturangaben. Gefördert von: Fundamental Research Funds for the Central Universities, National Key Research and Development Program of China, Major Scientific and Technological Innovation Project of Shandong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Xanthine OxidaseHyperuricemiaEnzyme InhibitorsAnimalsMiceMolecular Docking SimulationStructure-Activity RelationshipMolecular StructureDose-Response Relationship, DrugHumansMaleUric Acid

Stichwörter der Autor:innen

BromophenolHyperuricemiaUrate-lowering drugsXanthine oxidase

Substanzen

Xanthine OxidaseEnzyme InhibitorsUric Acid

Autor:innen und Institutionen

  • Key Laboratory of Marine Drugs, Ministry of Education, School of Medicine and Pharmacy, Ocean University of China, Qingdao 266003, China; Laboratory for Marine Drugs and Bioproducts, Qingdao Marine Science and Technolog…
  • Department of Biochemistry and Biotechnology, School of Health Sciences, University of Thessaly, Biopolis, Larissa 41500, Greece.

Förderung

  • Fundamental Research Funds for the Central Universities
  • National Key Research and Development Program of China
  • Major Scientific and Technological Innovation Project of Shandong Province

Zitieren

APA

Wang, Q., Wang, L., Guo, Y., Stagos, D., Liu, Y., & Liu, M. (2026). (1E,4E)-1,5-bis(2-bromo-4,5-dihydroxyphenyl)penta-1,4-dien-3-one alleviates hyperuricemia by inhibiting xanthine oxidase. Bioorganic Chemistry, 174, 109745. https://doi.org/10.1016/j.bioorg.2026.109745

Vancouver

Wang Q, Wang L, Guo Y, Stagos D, Liu Y, Liu M. (1E,4E)-1,5-bis(2-bromo-4,5-dihydroxyphenyl)penta-1,4-dien-3-one alleviates hyperuricemia by inhibiting xanthine oxidase. Bioorganic Chemistry. 2026;174:109745. doi:10.1016/j.bioorg.2026.109745

BibTeX
@article{Wang2026,
  author = {Wang, Qian and Wang, Li and Guo, Yaxin and Stagos, Dimitrios and Liu, Yankai and Liu, Ming},
  title = {(1E,4E)-1,5-bis(2-bromo-4,5-dihydroxyphenyl)penta-1,4-dien-3-one alleviates hyperuricemia by inhibiting xanthine oxidase},
  journal = {Bioorganic Chemistry},
  year = {2026},
  volume = {174},
  pages = {109745},
  doi = {10.1016/j.bioorg.2026.109745}
}
Kostenlos starten →